A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2006
12/13/2006	EP1171156B1 Isolierte inslen, die insulin-produzierende zellen enthalten, beschichtete mit heparin
12/13/2006	EP1143989B1 Exendins for glucagon suppression
12/13/2006	EP0760602B1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/13/2006	CN1878864A Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof
12/13/2006	CN1878768A Heteroaryl deravatives as PPAR activators
12/13/2006	CN1878760A Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt
12/13/2006	CN1878548A Combinations of at1-antagonists, amiloride or triamterine, and a diuretic.
12/13/2006	CN1876683A Human antibodies that bind human TNFalpha
12/13/2006	CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006	CN1876630A Preparation method of amorphous fluvastatin sodium
12/13/2006	CN1876629A Preparation method of amorphous atorvastatin calcium
12/13/2006	CN1876186A Endostatin conjugate and its preparation method
12/13/2006	CN1876146A A Chinese medicine for treating cardiovascular and cerebrovascular disease
12/13/2006	CN1876068A Process and application of Chinese medicinal preparation containing belamcanda
12/13/2006	CN1876059A A medicinal liquor for treating blood stasis obstruction type hyperlipemia and preparation method thereof
12/13/2006	CN1876042A A method for preparing fat-reducing medicine
12/13/2006	CN1876029A A medicine for treating uremia and diabetes
12/13/2006	CN1875994A Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/13/2006	CN1875993A A prescription of royal jelly and bee product and preparation method thereof
12/13/2006	CN1875981A Injection emulsion containing breviscapinum and preparation method thereof
12/13/2006	CN1289499C Pirazino (aza) indole derivatives
12/13/2006	CN1289496C Process for producing novel paroxetine hydrochloride anhydrate
12/13/2006	CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006	CN1289483C Heterocyclic derivatives of glycinamide and its pharmaceutical uses
12/13/2006	CN1289481C Biphenylcarboxamides useful as lipid lowering agents
12/13/2006	CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders
12/13/2006	CN1289467C Dibenzylamine compound and medicinal use thereof
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289143C Method for reducing decreasing blood-glucose and delaying weight increase of diabetic
12/13/2006	CN1289111C Medicine for lowering blood lipid and softening blood vessel and its preparing method
12/13/2006	CN1289107C Fig buccal tablet and its preparing process
12/13/2006	CN1289090C Highly selective norepinephrine reuptake inhibitors and use thereof in medicament preparation
12/13/2006	CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/13/2006	CN1289082C Medicine composition for treating diabetes
12/13/2006	CN1289081C Pharmaceutical composition for modified release insulin sensitiser
12/13/2006	CN1289080C Vegetable estrogen analogy composition capable of replacing estrogen and its application
12/13/2006	CN1289074C Method for preparing sodium ferulate sterilized raw-material medicine
12/13/2006	CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/13/2006	CN1289066C Glicetin -1 slow release microspheric preparation and its use
12/12/2006	US7148355 Process for the preparation of repaglinide
12/12/2006	US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal
12/12/2006	US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006	US7147877 Method for treating lesions caused by estrogen deficiency with extract of cucumber
12/12/2006	CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006	CA2159355C Method and composition for treatment of osteoporosis
12/12/2006	CA2121871C A prophylactic or therapeutic drug for renal diseases
12/12/2006	CA2098176C Angiotensin ii receptor blocking compositions
12/07/2006	WO2006130080A2 Quinoline derivatives as nk3 anatgonists
12/07/2006	WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	WO2006129859A2 Combinations of a squalene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia
12/07/2006	WO2006129826A1 Novel piperidine derivative
12/07/2006	WO2006129785A1 Concomitant pharmaceutical agents and use thereof
12/07/2006	WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006	WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006	WO2006129649A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof
12/07/2006	WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129524A1 Carbonyl compound remover
12/07/2006	WO2006129193A2 Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
12/07/2006	WO2006129095A2 Sustained release preparations of pro-insulin c-peptide
12/07/2006	WO2006128909A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/07/2006	WO2006128803A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/07/2006	WO2006128259A1 Substances having body mass redistribution properties
12/07/2006	WO2006103342A3 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/07/2006	WO2006086978A3 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds
12/07/2006	WO2006086445A8 Combination therapy
12/07/2006	WO2006052608A3 Treatment of obesity and related disorders
12/07/2006	US20060276522 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006	US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006	US20060276491 Therapeutic compounds
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276485 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276452 Use of azetidinecarboxamide derivatives in therapy
12/07/2006	US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability
12/07/2006	US20060276433 Hydrazone derivative
12/07/2006	US20060276432 Lipid-regulating agent and use thereof
12/07/2006	US20060276430 Formulations for mediating inflammation and for reducing blood cholesterol
12/07/2006	US20060276397 Crystallization of IGF-1
12/07/2006	US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein
12/07/2006	US20060276381 Remedy for diabetes
12/07/2006	US20060275359 Palliative effects of morinda citrifolia oil and juice
12/07/2006	US20060275319 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter
12/07/2006	US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
12/07/2006	US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006	US20060275274 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
12/07/2006	US20060275253 Beta hydroxy short to medium chain fatty acid polymer
12/07/2006	US20060275251 Polymer complexes of glucuronoglucanes
12/07/2006	CA2611060A1 Quinoline derivatives as nk3 antagonists
12/07/2006	CA2610671A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	CA2610152A1 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
12/07/2006	CA2609784A1 Novel method of treating hyperlipidemia
12/07/2006	CA2609783A1 Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
12/07/2006	CA2609388A1 Novel piperidine derivative
12/07/2006	CA2608865A1 Substances having body mass redistribution properties
12/07/2006	CA2608819A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/06/2006	EP1728790A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/06/2006	EP1728506A1 Coenzyme q composition with long-term persistence in blood

1 ... 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 ... 1298